Lenalidomide Combined With Rituximab as Front-line Therapy in Elderly Patients Aged Over 80 Years With Diffuse Large B Cell Lymphoma
Latest Information Update: 05 Apr 2023
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms R2DLBCL80
Most Recent Events
- 12 Nov 2020 New trial record